Stable Istotope Labelled Tovetumab Biosimilar – Anti-PDGFRA / PDGFR2/ CD140a mAb – Research Grade

Reference: PX-TA1328-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Istotope Labelled Tovetumab Biosimilar - Anti-PDGFRA / PDGFR2/ CD140a mAb - Research Grade
SourceCAS 1243266-04-7
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsMEDI-575
ReferencePX-TA1328-SIL
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG2-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information on Anti-PDGFRA / PDGFR2/ CD140a[Homo sapiens] (Tovetumab) Monoclonal Antibody

Tovetumab has been investigated for the treatment of Cancer, Glioblastoma Multiforme, and Advanced Solid Malignancies.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Istotope Labelled Tovetumab Biosimilar – Anti-PDGFRA / PDGFR2/ CD140a mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.